Luo Y, Yang SK, Zhou X, Wang M, Tang D, Liu FY, Sun L, Xiao L. Use of Ophiocordyceps sinensis (syn. Cordyceps sinensis) combined with angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) versus ACEI/ARB alone in the treatment of diabetic kidney disease: a meta-analysis. Ren Fail 2015;37:614-34. [PMID: 25682973 DOI: 10.3109/0886022X.2015.1009820][Cited by in Crossref: 4][Cited by in F6Publishing: 2][Article Influence: 0.6][Reference Citation Analysis]
Number
Citing Articles
1
Zhang L, Miao R, Yu T, Wei R, Tian F, Huang Y, Tong X, Zhao L. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106111][Reference Citation Analysis]
2
Liu W, Gao Y, Zhou Y, Yu F, Li X, Zhang N. Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review. Front Pharmacol 2022;13:881835. [DOI: 10.3389/fphar.2022.881835][Reference Citation Analysis]